Page last updated: 2024-08-20

citral and Glomerulosclerosis, Focal Segmental

citral has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, JM; Chen, A; Ho, CL; Hua, KF; Ka, SM; Kuoping Chao, L; Lin, YC; Yang, SM	1

Other Studies

1 other study(ies) available for citral and Glomerulosclerosis, Focal Segmental

Article	Year
Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice. PloS one, 2013, Volume: 8, Issue:9 Topics: Acyclic Monoterpenes; Animals; Apoptosis; Chemokine CCL2; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Inflammation; Macrophages; Male; Mice; Mitogen-Activated Protein Kinases; Monoterpenes; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Oxidative Stress; Podocytes; Reactive Oxygen Species; Signal Transduction	2013

Article

Year

Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice.

PloS one, 2013, Volume: 8, Issue:9

Topics: Acyclic Monoterpenes; Animals; Apoptosis; Chemokine CCL2; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Inflammation; Macrophages; Male; Mice; Mitogen-Activated Protein Kinases; Monoterpenes; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Oxidative Stress; Podocytes; Reactive Oxygen Species; Signal Transduction

2013